1Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002;2(3) :151 - 161.
2Zhao X, Deak E, Soderberg K, et al. Vaginal submucosal dendritic cells,but not Langerhans cells, induce protective Th1 responses to herpes simplex virus- 2. J Exp Med 2003;197(2) :153 - 162.
3Penna G, Vulcano M, Roncari A, et al. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 2002; 169(12) :6673 - 6676.
4Kurt- Jones EA, Chan M, Zhou S, et al. Herpes simplex virus 1 interaction with Toll - like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004;101(5):1315 - 1320.
5Homg T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001 ;2(9) :835 - 841.
6Lund J, Sato A, Akira S, et al. Toll - like receptor 9 - mediated recognition of herpes simplex virus - 2 by plasmacytoid dendritic cells. J Exp Med 2003;98(3):513- 520.
7Gill N, Deacon PM, Lichty B, et al. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll -like receptor ligands correlate with beta interferon production. J Virol 2006;80(20) :9943 - 9950.
8Megjugorac NJ, Young HA, Amrute SB, et al. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration ofT and NK cells. J Leukoc Biol 2004;75 (3) :504- 514.
9Sorensen LN, Paludan SR. Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs h,,sl defence and perturbs the cytokine response. Scand J Immunol 2004;59(3) :321 - 333.
10Ank N, Petersen K, Malmgaard L, et al. Age - dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2. J Virol 2005;79(15) :9831 - 9841.
